Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (21-30 of 408) with videos related to

Pageof 41
Sort By:
Diabetes, Obesity & Metabolism|April 14, 2017
Cardiovascular safety of insulin: Between real-world data and realityEdoardo Mannucci, Ele Ferrannini
International Journal of Clinical Practice. Supplement|December 3, 2003
Dyslipidaemia versus endothelial dysfunction: which is more important in the development of vascular disease?Ele Ferrannini, Jaakko Tuomilehto
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Pathophysiology, prevention and management of chronic kidney disease in the hypertensive patient with diabetes mellitusAnna Solini, Ele Ferrannini
Reviews in Endocrine & Metabolic Disorders|January 15, 2022
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative reviewStefania Camastra, Ele Ferrannini
Atherosclerosis. Supplements|July 11, 2006
Is insulin resistance atherogenic? A review of the evidenceEle Ferrannini, Patricia Iozzo
Diabetes Care|April 24, 2021
Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641-646Ele Ferrannini, Julio Rosenstock
Nature Reviews. Endocrinology|February 8, 2012
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospectsEle Ferrannini, Anna Solini
Diabetes Care|February 28, 2009
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetesEle Ferrannini, Geltrude Mingrone
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Hypertension, insulin resistance, and the metabolic syndromeAndrea Natali, Ele Ferrannini
Diabetes Care|June 22, 2021
Response to Comment on Ferrannini and Rosenstock. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641-646Ele Ferrannini, Julio Rosenstock
Pageof 41

Showing results (21-30 of 408) with videos related to

Sort By:
Pageof 41
Diabetes, Obesity & Metabolism|April 14, 2017
Cardiovascular safety of insulin: Between real-world data and realityEdoardo Mannucci, Ele Ferrannini
International Journal of Clinical Practice. Supplement|December 3, 2003
Dyslipidaemia versus endothelial dysfunction: which is more important in the development of vascular disease?Ele Ferrannini, Jaakko Tuomilehto
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Pathophysiology, prevention and management of chronic kidney disease in the hypertensive patient with diabetes mellitusAnna Solini, Ele Ferrannini
Reviews in Endocrine & Metabolic Disorders|January 15, 2022
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative reviewStefania Camastra, Ele Ferrannini
Atherosclerosis. Supplements|July 11, 2006
Is insulin resistance atherogenic? A review of the evidenceEle Ferrannini, Patricia Iozzo
Diabetes Care|April 24, 2021
Erratum. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641-646Ele Ferrannini, Julio Rosenstock
Nature Reviews. Endocrinology|February 8, 2012
SGLT2 inhibition in diabetes mellitus: rationale and clinical prospectsEle Ferrannini, Anna Solini
Diabetes Care|February 28, 2009
Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetesEle Ferrannini, Geltrude Mingrone
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Hypertension, insulin resistance, and the metabolic syndromeAndrea Natali, Ele Ferrannini
Diabetes Care|June 22, 2021
Response to Comment on Ferrannini and Rosenstock. Clinical Translation of Cardiovascular Outcome Trials in Type 2 Diabetes: Is There More or Is There Less Than Meets the Eye? Diabetes Care 2021;44:641-646Ele Ferrannini, Julio Rosenstock
Pageof 41